Bioforce Nanosciences Holdings Stock Short Ratio

BFNH Stock  USD 0.75  0.08  11.94%   
BioForce Nanosciences Holdings fundamentals help investors to digest information that contributes to BioForce Nanosciences' financial success or failures. It also enables traders to predict the movement of BioForce Pink Sheet. The fundamental analysis module provides a way to measure BioForce Nanosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioForce Nanosciences pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BioForce Nanosciences Holdings Company Short Ratio Analysis

BioForce Nanosciences' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

 = 

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition

Based on the latest financial disclosure, BioForce Nanosciences Holdings has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Packaged Foods industry. The short ratio for all United States stocks is 100.0% higher than that of the company.

BioForce Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioForce Nanosciences' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioForce Nanosciences could also be used in its relative valuation, which is a method of valuing BioForce Nanosciences by comparing valuation metrics of similar companies.
BioForce Nanosciences is currently under evaluation in short ratio category among its peers.

BioForce Fundamentals

About BioForce Nanosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BioForce Nanosciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioForce Nanosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioForce Nanosciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in BioForce Pink Sheet

BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.